SEARCH RESULT

Total Matching Records found : 283

Drug makers suffer an overdose of control-Bhupesh Bhandari

-The Business Standard The new price caps for 191 essential drugs are likely to introduce serious distortions in the market for these medicines The National Pharmaceutical Pricing Authority, or NPPA, has announced new price caps for 191 essential drugs that are 10 to 50 per cent lower than the current prices. Drug makers have 45 days to recall the earlier batches and send out new ones with the lower price tags. This...

More »

Paying the price-Ramya Kannan

-The Hindu     The much-awaited Drug (Prices Control) Order 2013 has disappointed millions of patients, as it lacks a fair formula to fix the price ceiling and leaves important drug classes out of regulation. The result: High out-of-pocket spending on medicines will continue As far as intentions go, the Drug (Prices Control) Order 2013 is aimed at making critical drugs affordable and available to the public, while preserving a rationale for manufacture by...

More »

Kerala tackles prejudice and prices -C Maya

-The Hindu     The State population stands at a little over three crore, but average consumption of drugs is three times the national average In Kerala, where people have a marked preference for branded drugs, where the most expensive brand is considered the best, and only those brands pushed by doctors sell, the new Drug (Prices Control) Order, which is expected to cut prices by 20-25 per cent, may not have much of...

More »

Health tips for caller tunes

-The Telegraph New Delhi: The World Health Organisation wants India's public to give up Bollywood songs as caller tunes on their mobile phones and replace them with short health messages from superstars of India's entertainment industry. The global health agency today launched what is being dubbed as the world's first attempt to promote health campaigns via caller tunes, drawing on the voices of 10 personalities from Bollywood and other entertainment sectors. Amitabh Bachchan's...

More »

Govt bans popular diabetes drug and analgin -Rupali Mukherjee

-The Times of India MUMBAI: The government has banned three popular medicines-the widely prescribed anti-diabetes drug pioglitazone, painkiller analgin and anti-depressant deanxit-in the wake of health risks associated with them. While it's believed that pioglitazone can cause heart failure and increases the risk of bladder cancer, analgin has been discarded the world over on grounds of patient safety. Deanxit, on the other hand is a harmful combination, which has been long...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close